Formoterol Clinical Trials

• A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients
  ClinicalTrials.gov Identifier: NCT00206154 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease
  
• Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)
  ClinicalTrials.gov Identifier: NCT00383435 - Recruiting
  Chronic Obstructive Pulmonary Disease (COPD)
  
• Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04230AM2)
  ClinicalTrials.gov Identifier: NCT00383721 - Recruiting
  Chronic Obstructive Pulmonary Disease (COPD)
  
• Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
  ClinicalTrials.gov Identifier: NCT00413387 - Completed
  Bronchial Asthma
  
• A Six-Week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in COPD
  ClinicalTrials.gov Identifier: NCT00239421 - Active, not recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Budesonide / Formoterol in Treatment of Exacerbations of COPD
  ClinicalTrials.gov Identifier: NCT00239278 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease (COPD)
  
• Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (Study P04139)
  ClinicalTrials.gov Identifier: NCT00379288 - Active, not recruiting
  Asthma
  
• Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma
  ClinicalTrials.gov Identifier: NCT00394199 - Active, not recruiting
  Asthma
  
• A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD
  ClinicalTrials.gov Identifier: NCT00419744 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma
  ClinicalTrials.gov Identifier: NCT00255255 - Active, not recruiting
  Asthma
  
• A 3-Week Multicenter Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients with Asthma
  ClinicalTrials.gov Identifier: NCT00130351 - Completed
  Asthma
  
• Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD
  ClinicalTrials.gov Identifier: NCT00476099 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD.
  ClinicalTrials.gov Identifier: NCT00489853 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Efficacy and Safety of Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination with Formoterol Certihaler in Patients with Stable Chronic Obstructive Pulmonary Disease.
  ClinicalTrials.gov Identifier: NCT00134979 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
  ClinicalTrials.gov Identifier: NCT00497237 - Recruiting
  Asthma
  
• Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma
  ClinicalTrials.gov Identifier: NCT00393991 - Recruiting
  Asthma
  
• Efficacy, Safety and Tolerability of Once-Daily (o.d.) Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily (b.i.d.) as Active Control
  ClinicalTrials.gov Identifier: NCT00393458 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease
  
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM1)
  ClinicalTrials.gov Identifier: NCT00381485 - Recruiting
  Asthma
  
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073)
  ClinicalTrials.gov Identifier: NCT00383552 - Recruiting
  Asthma
  
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics
  ClinicalTrials.gov Identifier: NCT00383240 - Recruiting
  Asthma
  
• New Combination Inhaler (Flutiform HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma
  ClinicalTrials.gov Identifier: NCT00393952 - Recruiting
  Asthma
  
• Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction
  ClinicalTrials.gov Identifier: NCT00460577 - Recruiting
  Acute Bronchial Obstruction, Asthma
  
• Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol
  ClinicalTrials.gov Identifier: NCT00569712 - Recruiting
  Lung Cancer; Precancerous/Nonmalignant Condition
  
• An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-Severe Persistent, Reversible Asthma
  ClinicalTrials.gov Identifier: NCT00563056 - Recruiting
  Asthma Bronchiale
  
• Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 Mg Twice Daily in Japanese Asthmatic Patients
  ClinicalTrials.gov Identifier: NCT00252785 - Active, not recruiting
  Asthma
  
• Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects with COPD
  ClinicalTrials.gov Identifier: NCT00064402 - Completed
  Chronic Obstructive Pulmonary Disease; Chronic Bronchitis; Emphysema
  
• To evaluate the long-term safety of (R,R)-formoterol in subjects with COPD
  ClinicalTrials.gov Identifier: NCT00064415 - Completed
  Chronic Obstructive Pulmonary Disease; Chronic Bronchitis; Emphysema
  
• Effectiveness and Safety of Tiotropium Bromide Alone Vs Tiotropium Bromide and Formoterol Fumarate in Subjects with COPD
  ClinicalTrials.gov Identifier: NCT00139932 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00288548 - Recruiting
  Chronic Obstructive Pulmonary Disease (COPD)
  
• Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations
  ClinicalTrials.gov Identifier: NCT00272753 - Completed
  Asthma
  
• Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg Formoterol
  ClinicalTrials.gov Identifier: NCT00327353 - Completed
  Asthma
  
• Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer)
  ClinicalTrials.gov Identifier: NCT00443482 - Completed
  Asthma
  
• Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00418509 - Completed
  Healthy
  
• Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol
  ClinicalTrials.gov Identifier: NCT00422552 - Completed
  COPD
  
• Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00476268 - Completed
  Asthma
  
• Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)
  ClinicalTrials.gov Identifier: NCT00314509 - Completed
  Asthma
  
• EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI
  ClinicalTrials.gov Identifier: NCT00394368 - Completed
  Bronchial Asthma
  
• A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD
  ClinicalTrials.gov Identifier: NCT00206167 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Effect of Symbicort on GR Localisation in Asthma
  ClinicalTrials.gov Identifier: NCT00159263 - Completed
  Asthma